Table 8.
Multivariate Cox regression analysis of survival rate in SC/ASC and AC patients.
Groups | Factors | SC/ASC | AC | ||
---|---|---|---|---|---|
P | HR (95%CI) | P | HR (95%CI) | ||
Differentiated degree | Well/moderately/poorly | 0.008 | 1.813 (1.166–2.818) | 0.001 | 1.567 (1.193–2.057) |
Tumor size | ≤3 cm/>3 cm | 0.022 | 2.560 (1.148–5.707) | 0.012 | 1.865 (1.149–3.026) |
Gallstone | No/Yes | 0.047 | 1.770 (1.009–3.107) | 0.005 | 1.728 (1.181–2.528) |
TNM stage | I + II/III + IV | 0.023 | 2.504 (1.134–5.528) | 0.017 | 2.399 (1.171–4.915) |
Lymph node metastasis | No/Yes | 0.018 | 3.155 (1.222–8.147) | 0.011 | 2.394 (1.220–4.698) |
Invasion | No/Yes | 0.027 | 3.394 (1.150–10.013) | 0.000 | 5.795 (2.913–11.530) |
Surgery | Radical/Palliative/Biopsy | 0.006 | 2.192 (1.254–3.833) | 0.000 | 2.540 (1.679–3.840) |
XBP1 | –/+ | 0.012 | 2.305 (1.205–4.409) | 0.003 | 1.848 (1.227–2.783) |
NAT1 | –/+ | 0.015 | 0.351 (0.151–0.813) | 0.000 | 0.472 (0.312–0.714) |
–, negative expression; +, positive expression; HR, hazard ratio; CI, confident interval.